Premium
Long‐term outcome after neuroleptic malignant syndrome
Author(s) -
Koponen H.,
Repo E.,
Lepola U.
Publication year - 1991
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.1991.tb03192.x
Subject(s) - neuroleptic malignant syndrome , medicine , dopaminergic , adverse effect , blockade , dopamine receptor , pediatrics , receptor , dopamine
Neuroleptic malignant syndrome (NMS) is a rare, life‐threatening adverse drug reaction caused by the blockade of central dopaminergic receptors by neuroleptics. In the acute phase, most patients recover, although marked mortality from complications of acute NMS still exist. The long‐term course after acute NMS is, however, still unclear. In this report we describe the follow‐up data from 12 patients.